<DOC>
	<DOC>NCT02367131</DOC>
	<brief_summary>Study to investigate the safety and efficacy of daily use of JARDIANCE速 Tablets in Japanese elderly patients with type 2 diabetes mellitus.</brief_summary>
	<brief_title>Daily Use of JARDIANCE速 Tablets in Japanese Elderly Patients With Type 2 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Empagliflozin</mesh_term>
	<criteria>Inclusion criteria: Male and female elderly patients (age 65 and over) with type 2 diabetes mellitus who have never been treated with JARDIANCE速 Tablets before the enrolment and start taking JARDIANCE速 Tablets within 3 months after launch in Japan Exclusion criteria:</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>